Altamira Therapeutics Ltd. Finance Costs
Altamira Therapeutics Ltd. (CYTOF) reported Finance Costs of $37.31 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2025-08-29
CHF
| Period end | Finance Costs 6 month | Finance Costs 12 month |
|---|---|---|
| 2023-06-30 | 861.12K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 1.60M CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | 377.99K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 1.74M CHF 20-F · filed 2023-05-16 | |
| 2020-12-31 | 6.15M CHF 20-F · filed 2023-05-16 | |
| 2019-12-31 | 1.59M CHF 20-F · filed 2022-04-12 | |
| 2018-12-31 | 2.31M CHF 20-F · filed 2021-03-31 | |
| 2017-12-31 | 4.38M CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 1.77M CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 670.09K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Finance Costs 6 month |
|---|---|
| 2025-06-30 | $37.31K 6-K · filed 2025-08-29 |
| 2024-06-30 | $186.00K 6-K · filed 2025-08-29 |
| 2023-06-30 | $937.59K 6-K · filed 2024-09-24 |